» Articles » PMID: 8671680

Selective Recognition of Malaria Antigens by Human Serum Antibodies is Not Genetically Determined but Demonstrates Some Features of Clonal Imprinting

Overview
Journal Int Immunol
Date 1996 Jun 1
PMID 8671680
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Malaria infection induces the production of serum antibodies to a variety of malaria antigens but the prevalence of antibodies to any particular antigen is typically much less than 100%. It has been assumed that non-responsiveness to defined antigens in malaria immune subjects is due to HLS-mediated restriction of the immune response. In this study we have investigated the role of HLA and non-HLA genes in the antibody response to two merozoite surface antigens (MSP1 and MSP2) and a sexual stage antigen (Ps260/230) of Plasmodium falciparum, and conclude that host genotype is not a major determinant of responsiveness. Although antibody levels vary in accordance with seasonal variations in malaria transmission in semi-immune children, antibody levels remain stable in clinically immune adults. Antigen recognition is selective with individual donors showing consistent high titre responses to some antigens/epitopes whilst consistently failing to recognize adjacent regions/epitopes of the same protein. An alternative explanation, consistent with the data presented here, is that selective antibody responses to malaria antigens in immune individuals result from a process akin to clonal imprinting (original antigenic sin).

Citing Articles

The impact of Plasmodium-driven immunoregulatory networks on immunity to malaria.

Boyle M, Engwerda C, Jagannathan P Nat Rev Immunol. 2024; 24(9):637-653.

PMID: 38862638 PMC: 11688169. DOI: 10.1038/s41577-024-01041-5.


Role of Human Twin Studies to Identify Genetic Linkage of Malaria Pathogenesis and Outcomes.

Biswas S, Nain M, Ahmad S, Sharma A Am J Trop Med Hyg. 2023; 109(2):241-247.

PMID: 37277110 PMC: 10397443. DOI: 10.4269/ajtmh.23-0028.


Variable immunogenicity of a vivax malaria blood-stage vaccine candidate.

De S, May S, Shah K, Slawinski M, Changrob S, Xu S Vaccine. 2021; 39(19):2668-2675.

PMID: 33840564 PMC: 8323509. DOI: 10.1016/j.vaccine.2021.03.072.


Proteome-wide analysis of a malaria vaccine study reveals personalized humoral immune profiles in Tanzanian adults.

Camponovo F, Campo J, Le T, Oberai A, Hung C, Pablo J Elife. 2020; 9.

PMID: 32662772 PMC: 7386907. DOI: 10.7554/eLife.53080.


B-cell memory in malaria: Myths and realities.

Perez-Mazliah D, Ndungu F, Aye R, Langhorne J Immunol Rev. 2019; 293(1):57-69.

PMID: 31733075 PMC: 6972598. DOI: 10.1111/imr.12822.